NantKwest

$28.14
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.05 (+4.08%) Today
+$1.34 (+5.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell NantKwest and other stocks, options, and ETFs commission-free!

About NK

NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA. The listed name for NK is NantKwest, Inc. Common Stock.

CEO
Richard Adcock
Employees
148
Headquarters
San Diego, California
Founded
2002
Market Cap
3.02B
Price-Earnings Ratio
Dividend Yield
Average Volume
1.78M
High Today
$28.24
Low Today
$23.15
Open Price
$28.22
Volume
1.34M
52 Week High
$45.42
52 Week Low
$2.52

NK Earnings

-$0.30
-$0.20
-$0.10
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
-$0.30 per share

You May Also Like

EWD
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure